Table 2.
Resveratrol in clinical trials for metabolic disorders.
| Status | Study Title | Conditions | Intervention | Phase | NCT Number |
|---|---|---|---|---|---|
| Completed | Effects of Resveratrol in Patients With Type 2 Diabetes | Type 2 Diabetes | 500 mg to a maximum dose of 3 g daily | Phase 1 | NCT01677611 |
| Terminated | Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes Mellitus | Type 2 Diabetes Mellitus | 500 mg 3 times daily | Phase 2 | NCT02549924 |
| Completed | Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans | Type 2 Diabetes Mellitus & Insulin Resistance | 1,000 mg twice daily for 28 days | Phase 2 | NCT01354977 |
| Completed | Regulation of Intestinal and Hepatic Lipoprotein Secretion by Resveratrol | Dyslipidaemia & Insulin Resistance | 500 mg for 1 week followed by 1 g for 1 week | Phase 2 | NCT01451918 |
| Completed | Effects of Dietary Antioxidants to Prevent Cardiovascular Disease | Hypercholesterolemia & Healthy | Dietary Supplement: red wine for 1 month Dietary Supplement: resveratrol for 1 month |
Phase 2 | NCT02409537 |
| Completed with results | Healthy Aging Through Functional Food | Glucose Intolerance & Aortic Stiffness & Vasodilation | Trans-resveratrol, 90 mg + hesperetin, 120 mg (combination) | Phase 1/2 | NCT02095873 |
| Completed | Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients | Type 2 Diabetes Mellitus & Inflammation & Insulin Resistance & Other Disorders of Bone Density and Structure | 6 months 40 mg daily then 6 months 500 mg daily | Phase 3 | NCT02244879 |
| Completed with results | Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion | Metabolic Syndrome X | 500 mg 3 times daily before meals with a total dose of 1,500 mg daily | Phase 2 | NCT02114892 |
| Completed | Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents | NAFLD & Type 2 Diabetes & Metabolic Syndrome | 75 mg twice daily for a total daily dose of 150 mg for 30 days | Phase 2/3 | NCT02216552 |
| Completed | A Study of Resveratrol as Treatment for Friedreich Ataxia | Friedreich Ataxia | 1 g daily (500 mg twice daily) for 12 weeks then 5 g daily (2.5 g twice daily) for 12 weeks | Phase 1/2 | NCT01339884 |
| Completed | Effect of Banaba (Lagerstroemia Speciosa) on Metabolic Syndrome, Insulin Secretion and Insulin Sensitivity | Metabolic Syndrome X | Banaba capsules, 500 mg, 2 times daily before meals for 90 days | Phase 2 | NCT02767869 |